Bristol-Myers Squibb
BMY
$48.93
Share price
1.30%
Change (1 day)
-29.96%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $65.67 B
According to Bristol-Myers Squibb's latest financial reports the company's total liabilities are $65.67 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Bristol-Myers Squibb - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $65.67 B | -0.04% |
| 2022-12-31 | $65.70 B | -10.38% |
| 2021-12-31 | $73.30 B | -9.05% |
| 2020-12-31 | $80.59 B | 3.01% |
| 2019-12-31 | $78.24 B | 275.12% |
| 2018-12-31 | $20.85 B | -3.89% |
| 2017-12-31 | $21.70 B | 25.02% |
| 2016-12-31 | $17.36 B | 0.21% |
| 2015-12-31 | $17.32 B | -7.68% |
| 2014-12-31 | $18.76 B | -19.65% |
| 2013-12-31 | $23.35 B | 4.93% |
| 2012-12-31 | $22.25 B | 30.15% |
| 2011-12-31 | $17.10 B | 10.79% |
| 2010-12-31 | $15.43 B | -4.84% |
| 2009-12-31 | $16.22 B | -6.11% |
| 2008-12-31 | $17.27 B | 10.69% |
| 2007-12-31 | $15.61 B | 0.17% |
| 2006-12-31 | $15.58 B | -7.95% |
| 2005-12-31 | $16.93 B | -16.32% |
| 2004-12-31 | $20.23 B | 14.56% |
| 2003-12-31 | $17.66 B | 8.58% |
| 2002-12-31 | $16.26 B | -13.19% |
| 2001-12-31 | $18.73 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 50.42% | 🇺🇸 USA |
 Novartis NVS | $53.19 B | -19.00% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 108.93% | 🇺🇸 USA |
 AbbVie ABBV | $124.31 B | 89.29% | 🇺🇸 USA |
 Eli Lilly LLY | $53.14 B | -19.08% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 38.44% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | -12.27% | 🇫🇷 France |
 Biogen BIIB | $12.04 B | -81.66% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 5.13% | 🇺🇸 USA |
 AstraZeneca AZN | $61.95 B | -5.67% | 🇬🇧 UK |